A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab
一项随机 II 期临床试验,旨在评估使用高剂量利沙珠单抗治疗中重度斑块状银屑病患者的疗效。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67475-0
Blauvelt, Andrew; Jiang, Rundong; Shi, Linyu; Tsoi, Lam C; Bogle, Rachael; Fox, Jennifer; Gharaee-Kermani, Mehrnaz; Billi, Allison C; Matheson, Robert T; Photowala, Huzefa; Gudjonsson, Johann E; Ehst, Benjamin D